Hence, suppression of this negative feedback by mTORci activates PI3 K signalling and in some cancers, chronic exposure to mTORci is reported to over-activate the MEK/ERK pathway, paradoxically opposing the anti-proliferative effect of mTORci52,53. This evidence concerns the gene MAP2K7 and cancer.